Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-14

Clinical Trial Update: A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome Measures

View source ↗

Summary

A completed head-to-head clinical trial comparing AVAMYS (mometasone furoate) with NASONEX (mometasone furoate) and Flixonase (fluticasone propionate) on key he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Avamys (fluticasone furoate)
  • Flixonase (fluticasone propionate)
  • Nasonex (mometasone furoate)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial | Status: COMPLETED